The Joint Corp. (NASDAQ:JYNT) Short Interest Update

The Joint Corp. (NASDAQ:JYNT) was the recipient of a large decrease in short interest in the month of July. As of July 15th, there was short interest totalling 454,700 shares, a decrease of 14.8% from the June 30th total of 533,600 shares. Based on an average daily trading volume, of 64,200 shares, the days-to-cover ratio is presently 7.1 days.

Joint Stock Performance

JYNT traded down $0.09 on Wednesday, hitting $14.42. The company had a trading volume of 42,100 shares, compared to its average volume of 77,888. The stock has a fifty day moving average price of $14.36 and a 200-day moving average price of $12.77. Joint has a 12-month low of $7.31 and a 12-month high of $17.82. The stock has a market capitalization of $215.87 million, a price-to-earnings ratio of -19.36 and a beta of 1.60.

Joint (NASDAQ:JYNT) last released its earnings results on Thursday, May 2nd. The company reported $0.06 EPS for the quarter, topping analysts’ consensus estimates of ($0.03) by $0.09. Joint had a positive return on equity of 3.94% and a negative net margin of 9.24%. The firm had revenue of $29.72 million during the quarter, compared to the consensus estimate of $29.17 million. Analysts forecast that Joint will post 0.2 EPS for the current fiscal year.

Analyst Ratings Changes

Several analysts recently commented on JYNT shares. Roth Mkm reissued a “buy” rating and set a $16.00 price objective (up from $13.00) on shares of Joint in a research report on Friday, May 3rd. B. Riley increased their price objective on shares of Joint from $12.00 to $20.00 and gave the stock a “buy” rating in a research note on Monday, May 6th. Finally, StockNews.com raised shares of Joint from a “hold” rating to a “buy” rating in a report on Monday, May 6th. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, Joint has an average rating of “Moderate Buy” and a consensus price target of $22.00.

Institutional Investors Weigh In On Joint

A number of institutional investors and hedge funds have recently modified their holdings of the company. Russell Investments Group Ltd. acquired a new position in shares of Joint in the 4th quarter valued at $795,000. Skylands Capital LLC lifted its stake in shares of Joint by 20.3% in the 4th quarter. Skylands Capital LLC now owns 603,640 shares of the company’s stock valued at $5,801,000 after purchasing an additional 101,850 shares during the period. Boston Partners acquired a new position in shares of Joint in the 4th quarter valued at $279,000. Trexquant Investment LP lifted its stake in shares of Joint by 8.0% in the 4th quarter. Trexquant Investment LP now owns 82,686 shares of the company’s stock valued at $795,000 after purchasing an additional 6,097 shares during the period. Finally, Bard Associates Inc. lifted its stake in shares of Joint by 4.3% in the 4th quarter. Bard Associates Inc. now owns 79,549 shares of the company’s stock valued at $764,000 after purchasing an additional 3,250 shares during the period. Institutional investors and hedge funds own 76.88% of the company’s stock.

Joint Company Profile

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.